期刊文献+

身痛逐瘀汤联合普瑞巴林、甲钴胺治疗痛性糖尿病周围神经病变的疗效观察 被引量:10

Effective observation on treating painful diabetic peripheral neuropathy with the Shentong Zhuyu decoction plus pregabalin and mecobalamin
下载PDF
导出
摘要 目的:观察普瑞巴林、甲钴胺联合中药汤剂身痛逐瘀汤,用于糖尿病周围神经病变治疗的有效性、可行性。方法:以2015年7月-2016年5月我院收治的64例痛性糖尿病周围神经病变患者为研究对象,并采用双盲法对患者进行随机分组,本次临床将患者分为单一组、中西组,每组32例。单一组用普瑞巴林、甲钴胺,中西组加用身痛逐瘀汤,观察治疗前后患者神经反射情况,对患者治疗效果以及疼痛改善情况进行评估。结果:中西组改善有效率为96.9%,明显高于单一组的87.5%,中西组治疗效果好,同时用药后两组疼痛感均有明显改善,中西组较单一组患者疼痛感减轻效果好,P <0.05。入院时患者神经反射功能测评比较,差异无统计学意义,P> 0.05;用药后中西组神经反射功能恢复明显优于单一组,差异具有统计学意义,P<0.05。结论:临床对痛性糖尿病周围神经病变患者治疗时,以普瑞巴林、甲钴胺联合身痛逐瘀汤治疗,患者神经功能恢复好、疼痛改善好。 Objective: To observe clinical efficacy of the Shentong Zhuyu decoction (身痛逐瘀汤 ) plus pregabalin and mecobalamin on painful diabetic peripheral neuropathy. Methods: From July 2015 to May 2016, 64 cases were divided into two groups, 32 cases in each. The control group was given conventional western medicine, including pregabalin and inecobalamin; and the integrative medicine group was given the Shentong Zhuyu decoction. Results: The efficiency in the integrative medicine group was 96.9%, higher than 87.5% in the control group. After treatment, the pain sensation of both groups were significantly improved, and the effect in the integrative medicine group was better, p〈0.05. The recovery of nerve reflex function in the integrative medicine group was significantly better, P〈0.05. Conclusion: The Shentong Zhuyu decoction plus pregabalin and mecobalamin on painful diabetic peripheral neuropathy show a good effect, can improve clinical symptoms.
机构地区 韶关市中医院
出处 《中医临床研究》 2018年第32期40-42,共3页 Clinical Journal Of Chinese Medicine
关键词 疗效 甲钴胺 痛性糖尿病周围神经病变 身痛逐瘀汤 普瑞巴林 Efficacy Mecobalamin Painful diabetic peripheral neuropathy The Shentong Zhuyu decoction Pregabalin
  • 相关文献

二级参考文献65

  • 1葛星.血府逐瘀汤治疗糖尿病周围神经病变32例临床观察[J].浙江中医杂志,2007,42(5):271-271. 被引量:8
  • 2Ameriesn Diabetes Association. Executive summary: standards of medical care in diabetes-2010 [J].Diabetes Care,2010,33 (sl): 4- 10.
  • 3Ziegler D.Management of painful diabetic neuropathy:what is new or in the pipiline for 2007 [ J ].Curt Diab Rep, 2007,7 ( 6 ) : 409-415.
  • 4Katz J, Melzack R.Measurement of pain[ J ].Surg Clin North Am, 1999, 79(2) :231-252.
  • 5Sadosky A, McDermott AM,Brandenburg NA,et al.A review of the epidemiology of painful diabetic peripheral neuropahy,postherpetic neuralgia, and less commonly studied neuropathic pain condiations [J ]. Pain Pract, 2008,8 ( 1 ) :45-56.
  • 6Duby Ⅱ, Canmbell RK,Setter SM,et al.Diabetic neuropathy:an intensive rebiew[ J ].Am J Health Syst Pham, 2004,24(2) : 90-92.
  • 7Kamei N,Yamane K,Nakanishi S,et al.Effectiveness of Semmes- Weinstein monofilament examination for diabetic peripheral neuropathy screening[J].J Diabetes Complications, 2005,19( 1 ):47-53.
  • 8Tzellos TG, Papazisis G, Toulis KA, et al. ct2-a ligands gabapentin and pregabalin: future implications in daily clinical practice[ J ].Hippokratia, 2010,14(2) : 71-75.
  • 9Bian F,Li Z,Offord J,et al.Calcium channel ct2-cr type I subunit is the major binding protein for pregabalin in neocortex,hippocampus, amygdala, and spinal cord :an ex vivo autradiographic study in ct2-cr type I genetically modified mice[J].Brain Res, 2006,1075( 1 ) : 68-80.
  • 10Field M J, Cox PJ, Stott E, et al.Identification of the ct2-a type I subunit of voltage-dependent calcium channels as a molecular target for pain mediating the analgesic actions of pregabalin[J]. Proc Natl Acad Sci USA, 2006,103(46) : 17537-17542.

共引文献90

同被引文献111

引证文献10

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部